Search Results - "Wible, James H."

Refine Results
  1. 1

    Bioeffects Considerations for Diagnostic Ultrasound Contrast Agents by Miller, Douglas L., Averkiou, Michalakis A., Brayman, Andrew A., Everbach, E. Carr, Holland, Christy K., Wible, James H., Wu, Junru

    Published in Journal of ultrasound in medicine (01-04-2008)
    “…Diagnostic ultrasound contrast agents have been developed for enhancing the echogenicity of blood and for delineating other structures of the body. Approved…”
    Get full text
    Journal Article
  2. 2

    Biodistribution of diclofenac following repeated topical applications of two diclofenac sodium formulations to minipigs by Wible Jr, James H., Barrett, Thomas, Devarakonda, Krishna, Giuliani, Michael

    Published in Biopharmaceutics & drug disposition (01-03-2014)
    “…ABSTRACT This study evaluated diclofenac concentrations in plasma, selected hind limb tissues and synovial fluid after repeated topical applications of two…”
    Get full text
    Journal Article
  3. 3

    Measurement of Serum Calcium Concentration After Administration of Four Gadolinium-Based Contrast Agents to Human Volunteers by Brown, Jeffery J, Hynes, Michael R, Wible, James H., Jr

    Published in American journal of roentgenology (1976) (01-12-2007)
    “…The purpose of this study was to use three analytic methods to measure serum calcium concentration to assess the magnitude and time course of the effects of…”
    Get full text
    Journal Article
  4. 4

    Detection of Individual Microbubbles of Ultrasound Contrast Agents: Imaging of Free-Floating and Targeted Bubbles by Klibanov, Alexander L, Rasche, Peter T, Hughes, Michael S, Wojdyla, Jolette K, Galen, Karen P, Wible, James H, Brandenburger, Gary H

    Published in Investigative radiology (01-03-2004)
    “…RATIONALE AND OBJECTIVES:During echo examinations with microbubble contrast, individual “dots” of ultrasound reflection can be visualized. To address the…”
    Get full text
    Journal Article
  5. 5

    Microbubbles induce renal hemorrhage when exposed to diagnostic ultrasound in anesthetized rats by Wible, Jr, James H, Galen, Karen P, Wojdyla, Jolette K, Hughes, Michael S, Klibanov, Alexander L, Brandenburger, Gary H

    Published in Ultrasound in medicine & biology (01-11-2002)
    “…The generation of ultrasound (US) bioeffects using a clinical imaging system is controversial. We tested the hypothesis that the presence of microbubbles in…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Pharmacokinetics of gadoversetamide injection, a gadolinium-based contrast agent, in pediatric patients by Wible, James H, Tata, Prasad N.V, Napoli, Alicia M, Lowe, Lisa H, Kearns, Gregory L

    Published in Magnetic resonance imaging (01-05-2009)
    “…Abstract Objective The pharmacokinetics of gadoversetamide were examined in pediatric patients scheduled to undergo contrast-enhanced MRI of the central…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Measurement of serum calcium concentration after administration of gadoversetamide in dogs by Wible, Jr, James H, Hynes, Michael R

    Published in Radiology (01-10-2004)
    “…To measure serum calcium concentration with three different analytic methods after administration of gadoversetamide and three other gadolinium chelates in…”
    Get more information
    Journal Article
  10. 10

    The safety and efficacy of neuroimaging with gadoversetamide injection in pediatric patients by Lowe, Lisa H., Kearns, Gregory L., Wible, James H.

    Published in Current medical research and opinion (01-12-2006)
    “…ABSTRACT Objective: The safety and efficacy of gadoversetamide injection (OptiMARK*) was examined in pediatric patients referred for magnetic resonance imaging…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Safety assessment of gadoversetamide (OptiMARK®) administered by power injector by Abdou, Nancy, Napoli, Alicia M., Hynes, Michael R., Allen Jr, John C., Wible Jr, James H.

    Published in Journal of magnetic resonance imaging (01-01-2004)
    “…Purpose To evaluate the safety of OptiMARK® (gadoversetamide injection) administered via power injector. Materials and Methods The study population included…”
    Get full text
    Journal Article
  13. 13

    Pharmacokinetics and Safety of the MRI Contrast Agent Gadoversetamide Injection (Optimark) in Healthy Pediatric Subjects by Baker, James F, Kratz, Linda C, Stevens, Gary R, Wible, James H

    Published in Investigative radiology (01-06-2004)
    “…RATIONAL AND OBJECTIVE:This clinical trial examined the pharmacokinetics of gadoversetamide, a magnetic resonance imaging contrast agent, in normal pediatric…”
    Get full text
    Journal Article
  14. 14

    Cardiac magnetic resonance imaging safety following percutaneous coronary intervention by Curtis, Jason W., Lesniak, Donna C., Wible, James H., Woodard, Pamela K.

    “…In the first 8 weeks after percutaneous coronary intervention (PCI), possible negative interactions exist between the cardiac magnetic resonance (CMR) imaging…”
    Get full text
    Journal Article
  15. 15

    Cardiovascular Effects Caused by Rapid Administration of Gadoversetamide Injection in Anesthetized Dogs by WIBLE, JAMES H, GALEN, KAREN P, WOJDYLA, JOLETTE K

    Published in Investigative radiology (01-05-2001)
    “…Wible JH, Galen KP, Wojdyla J. Cardiovascular effects caused by rapid administration of gadoversetamide injection in anesthetized dogs. Invest Radiol…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Cardiovascular Effects of β-Carbolines in Conscious Rats by Wible, James H., Luft, Friedrich C., Stock, Daniel, DiMicco, Joseph A.

    Published in Hypertension Research (1996)
    “…The β-carbolines have a high affinity for the benzodiazepine receptor, where they demonstrate actions opposite to those of the benzodiazepines and elicit…”
    Get full text
    Journal Article
  18. 18

    Toxicological Assessment of Gadoversetamide Injection (OptiMARK®), a New Contrast-Enhancement Agent for Use in Magnetic Resonance Imaging by WIBLE, JAMES H, TROUP, CATHERINE M, HYNES, MICHAEL R, GALEN, KAREN P, MacDONALD, JANICE R, BARCO, STEVEN J, WOJDYLA, JOLETTE K, PERIASAMY, M PERI, ADAMS, MAX D

    Published in Investigative radiology (01-07-2001)
    “…Wible JH, Troup CM, Hynes MR, et al. Toxicological assessment of gadoversetamide injection (OptiMARK®), a new contrast-enhancement agent for use in magnetic…”
    Get full text
    Journal Article
  19. 19

    Direct Video-Microscopic Observation of the Dynamic Effects of Medical Ultrasound on Ultrasound Contrast Microspheres by KLIBANOV, ALEXANDER L, FERRARA, KATHERINE W, HUGHES, MICHAEL S, WIBLE, JAMES H, WOJDYLA, JOLETTE K, DAYTON, PAUL A, MORGAN, KAREN E, BRANDENBURGER, GARY H

    Published in Investigative radiology (01-12-1998)
    “…RATIONALE AND OBJECTIVES.Ultrasound can cause destruction of microbubble contrast agents used to enhance medical ultrasound imaging. This study sought to…”
    Get full text
    Journal Article
  20. 20

    Abstract 5516: Biodistribution of liposomal docetaxel prodrug MNK-010 in mice bearing A549 human NSCLC xenografts by Fitch, Richard M., Wible, James H., Blackledge, James A., McGhee, William D.

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…The anti-mitotic taxanes belong to one of the most important families of anticancer drugs that have broad anti-tumor activity and are widely used for a variety…”
    Get full text
    Journal Article